Hepatitis C News and Research

Latest Hepatitis C News and Research

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.

13 Apr 2020

Many of Washington State’s illicit drug users want to reduce use

A new survey of people who inject illicit drugs in the state of Washington yields positive and important findings for policy makers as the world struggles to deal with the COVID-19 pandemic, said authors of the survey by the University of Washington and Public Health-Seattle & King County.

11 Apr 2020

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

Deaths of children and adolescents in China due to infectious diseases were becoming rare prior to the COVID-19 pandemic, according to a new study.

3 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

AI tool could accurately predict which COVID-19 patients will develop respiratory disease

An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.

30 Mar 2020

Addiction is ‘a disease of isolation’ — so pandemic puts recovery at risk

Before the coronavirus became a pandemic, Emma went to an Alcoholics Anonymous meeting every week in the Boston area and to another support group at her methadone clinic. She said she felt safe, secure and never judged.

30 Mar 2020

New test uses saliva sample to provide immediate hepatitis B diagnosis

Viruses are sneaky beings. As the coronavirus pandemic is demonstrating, they cross borders quickly and can be highly contagious before symptoms of disease break out. In many cases of infection, a clear path of transmission cannot be determined.

27 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Research reveals rising rates of liver cancer

New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

23 Mar 2020

Was the novel coronavirus really sneaky in its spread to the U.S.? Experts say no

Unveiling a series of policies meant to mitigate the threat of COVID-19, President Donald Trump also sought to respond to criticism that his administration has been slow to deal with what is now a worldwide pandemic.

19 Mar 2020

Low-dose aspirin linked to lower risk of hepatocellular carcinoma and liver-related mortality

Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes.

12 Mar 2020

Researchers discover human protein that potently inhibits coronavirus

A protein produced by the human immune system can potently inhibit several coronaviruses, including the one behind the current COVID-19 outbreak, an international team of investigators reports today. The research reveals that the LY6E protein impairs the coronavirus' ability to initiate infection, which could lead to treatments for the illness.

10 Mar 2020

Liver fibrosis associated with one type of heart failure, regardless of HIV or hepatitis C status

While there is an association between liver fibrosis and heart failure, the mechanisms for this association are currently unclear but may be of particular importance for people living with human immunodeficiency virus (HIV) and/or hepatitis C, both of which are chronic infections that affect the liver and heart.

7 Mar 2020

UT Extension leads new effort to combat opioid crisis in rural Tennessee

University of Tennessee Extension will lead a new effort to combat the opioid crisis in rural Tennessee. PROMPT TN (Preventing Rural Opioid Misuse Through Partnerships and Training) will combine the expertise of multiple institutions to develop opioid-specific resources designed to increase understanding of underlying causes of opioid misuse with the goal of preventing addiction.

3 Mar 2020

Updated USPSTF recommendations on hepatitis C screening

The U.S. Preventive Services Task Force (USPSTF) now recommends the hepatitis C virus (HCV) infection screening for adults in the age group 18 to 79 years. This update comes against the background of increasing HCV over the last ten years, primarily due to higher injection drug use, and closer monitoring. The recommendation ensures that this screening will be covered by insurance as well without cost-sharing.

2 Mar 2020

New direct-acting antiviral therapies effectively target Hepatitis C virus

New direct-acting antiviral therapies are highly effective at eliminating the Hepatitis C virus infection, according to a systematic evidence review by researchers at Oregon Health & Science University.

2 Mar 2020

Drug for Ebola and MERS effective against COVID-19

A new study published in the Journal of Biological Chemistry has revealed that drug Remdesivir could be useful in treating the deadly COVID-19 or the novel coronavirus that is infecting tens of thousands of people across the world.

1 Mar 2020

Trusting injection drug users with IV antibiotics at home: It can work

Two mornings a week, Arthur Jackson clears space on half of his cream-colored sofa. He sets out a few rolls of tape and some gauze, then waits for a knock on his front door.

26 Feb 2020

Novartis and DNDi to partner on development of new oral treatment for visceral leishmaniasis

Novartis and the Drugs for Neglected Diseases initiative, a not-for-profit research and development organization, have signed a collaboration and license agreement to jointly develop LXE408, as a potential new oral treatment for visceral leishmaniasis, one of the world's leading parasitic killers.

25 Feb 2020

Scientists developing a combined vaccine to fight most malignant brain tumor

Scientists are developing a combined vaccine to fight the most deadly form of brain cancer.

25 Feb 2020

Hepatitis C News and Research

Latest Hepatitis C News and Research

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

Many of Washington State’s illicit drug users want to reduce use

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

Putting an end to the pandemic

AI tool could accurately predict which COVID-19 patients will develop respiratory disease

Addiction is ‘a disease of isolation’ — so pandemic puts recovery at risk

New test uses saliva sample to provide immediate hepatitis B diagnosis

New research initiative to investigate multi-species response to novel coronavirus

Research reveals rising rates of liver cancer

Was the novel coronavirus really sneaky in its spread to the U.S.? Experts say no

Low-dose aspirin linked to lower risk of hepatocellular carcinoma and liver-related mortality

Researchers discover human protein that potently inhibits coronavirus

Liver fibrosis associated with one type of heart failure, regardless of HIV or hepatitis C status

UT Extension leads new effort to combat opioid crisis in rural Tennessee

Updated USPSTF recommendations on hepatitis C screening

New direct-acting antiviral therapies effectively target Hepatitis C virus

Drug for Ebola and MERS effective against COVID-19

Trusting injection drug users with IV antibiotics at home: It can work

Novartis and DNDi to partner on development of new oral treatment for visceral leishmaniasis

Scientists developing a combined vaccine to fight most malignant brain tumor

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in